Indofarma Tbk - Asset Resilience Ratio

Latest as of September 2023: 16.37%

Indofarma Tbk (INAF) has an Asset Resilience Ratio of 16.37% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Indofarma Tbk to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rp244.05 Billion

≈ $14.30 Million USD Cash + Short-term Investments

Total Assets

Rp1.49 Trillion

≈ $87.37 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2022)

This chart shows how Indofarma Tbk's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see INAF total asset value.

Liquid Assets Composition Over Time

This chart breaks down Indofarma Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore INAF long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rp209.05 Billion	14.02%
Short-term Investments	Rp35.00 Billion	2.35%
Total Liquid Assets	Rp244.05 Billion	16.37%

Asset Resilience Insights

Good Liquidity Position: Indofarma Tbk maintains a healthy 16.37% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Indofarma Tbk Industry Peers by Asset Resilience Ratio

Compare Indofarma Tbk's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Shenzhen Kangtai Biological Products Co Ltd SHE:300601	Drug Manufacturers - Specialty & Generic	12.99%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%
ChengDa Pharmaceuticals Co. Ltd. SHE:301201	Drug Manufacturers - Specialty & Generic	32.14%

Annual Asset Resilience Ratio for Indofarma Tbk (2000–2022)

The table below shows the annual Asset Resilience Ratio data for Indofarma Tbk.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	20.04%	Rp307.44 Billion ≈ $18.01 Million	Rp1.53 Trillion ≈ $89.89 Million	+1.29pp
2021-12-31	18.76%	Rp377.34 Billion ≈ $22.11 Million	Rp2.01 Trillion ≈ $117.89 Million	+13.87pp
2020-12-31	4.88%	Rp83.65 Billion ≈ $4.90 Million	Rp1.71 Trillion ≈ $100.39 Million	+5.86pp
2019-12-31	-0.98%	Rp-13.57 Billion ≈ $-795.26K	Rp1.38 Trillion ≈ $81.09 Million	-0.03pp
2018-12-31	-0.95%	Rp-13.76 Billion ≈ $-806.07K	Rp1.44 Trillion ≈ $84.52 Million	-0.04pp
2017-12-31	-0.91%	Rp-13.93 Billion ≈ $-816.30K	Rp1.53 Trillion ≈ $89.64 Million	+0.11pp
2016-12-31	-1.02%	Rp-14.11 Billion ≈ $-826.88K	Rp1.38 Trillion ≈ $80.96 Million	-0.09pp
2015-12-31	-0.93%	Rp-14.29 Billion ≈ $-837.45K	Rp1.53 Trillion ≈ $89.87 Million	-0.93pp
2011-12-31	0.00%	Rp28.00 Million ≈ $1.64K	Rp1.11 Trillion ≈ $65.33 Million	0.00pp
2010-12-31	0.00%	Rp30.50 Million ≈ $1.79K	Rp733.96 Billion ≈ $43.01 Million	+0.00pp
2009-12-31	0.00%	Rp25.00 Million ≈ $1.46K	Rp728.03 Billion ≈ $42.66 Million	+0.00pp
2008-12-31	0.00%	Rp25.00 Million ≈ $1.46K	Rp965.81 Billion ≈ $56.59 Million	-0.23pp
2007-12-31	0.23%	Rp2.34 Billion ≈ $136.88K	Rp1.01 Trillion ≈ $59.15 Million	-0.99pp
2006-12-31	1.22%	Rp8.39 Billion ≈ $491.33K	Rp686.94 Billion ≈ $40.25 Million	-0.72pp
2005-12-31	1.94%	Rp10.08 Billion ≈ $590.68K	Rp518.82 Billion ≈ $30.40 Million	-5.71pp
2004-12-31	7.65%	Rp40.08 Billion ≈ $2.35 Million	Rp523.92 Billion ≈ $30.70 Million	+3.17pp
2003-12-31	4.48%	Rp28.50 Billion ≈ $1.67 Million	Rp635.96 Billion ≈ $37.26 Million	-0.51pp
2002-12-31	4.99%	Rp40.44 Billion ≈ $2.37 Million	Rp810.03 Billion ≈ $47.46 Million	-1.40pp
2001-12-31	6.39%	Rp51.89 Billion ≈ $3.04 Million	Rp811.62 Billion ≈ $47.56 Million	-3.24pp
2000-12-31	9.63%	Rp51.85 Billion ≈ $3.04 Million	Rp538.17 Billion ≈ $31.53 Million	--

pp = percentage points

About Indofarma Tbk

JK:INAF Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$22.88 Million

Rp390.51 Billion IDR

Market Cap Rank

#24779 Global

#524 in Indonesia

Share Price

Rp126.00

Change (1 day)

+0.00%

52-Week Range

Rp126.00 - Rp126.00

All Time High

Rp6975.00